Postoperative Complications After Splenectomy for Hematologic Malignancies
نویسندگان
چکیده
منابع مشابه
Vascular complications after splenectomy for hematologic disorders.
The most widely recognized long-term risk of splenectomy is overwhelming bacterial infection. More recently, thrombosis has become appreciated as another potential complication of the procedure. Because of these long-term risks, the indications for and timing of splenectomy are debated in the medical community. Accordingly, the adverse effects and benefits of splenectomy for hematologic disorde...
متن کاملPostoperative Splenectomy Complications
.. Objectives: To analyze the complications following elective splenectomy. Study Design: Descriptive crosssectional. Setting and Duration: This study was conducted in the department of surgery, Madinah Teaching Hospital, Faisalabad from January 2011 to December 2016. Method: After a good preoperative workup and preparation, 112 patients underwent elective open splenectomy from Jan 2011 to Dec ...
متن کاملComplications of patients with hematologic malignancies in a selected Iranian population
Background: Hematologic malignancies in childhood and their treatments can cause dental anomalies and jaw bone abnormalities; therefore, the aim of this study was to assess the prevalence of these disorders in children. Methods: This cross-sectional study was conducted on all children diagnosed with hematologic malignancies that referred to in Amirkola Children’s Hospital from 2011 to 2018. Al...
متن کاملHematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.
PURPOSE The purpose of this study was to define the hematologic response to total splenectomy (TS) or partial splenectomy (PS) in children with hereditary spherocytosis (HS) or sickle cell disease (SCD). METHODS The Splenectomy in Congenital Hemolytic Anemia (SICHA) consortium registry collected hematologic outcomes of children with CHA undergoing TS or PS to 1 year after surgery. Using rando...
متن کاملHematologic Malignancies
Touch MEdical MEdia 43 Multiple myeloma (MM) is an incurable plasma cell disease that comprises 1 % of all cancers and 10 % of hematologic malignancies. It primarily affects older individuals—the median age at the moment of diagnosis is 70 years—and two-thirds of multiple myeloma patients are over 65 years of age when they are first diagnosed. The outcome of MM patients has significantly improv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Surgery
سال: 1996
ISSN: 0003-4932
DOI: 10.1097/00000658-199603000-00010